Word: whose
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...victim, whose name is redacted from the report, told police that three black males, all between 19 and 21 years of age, attacked him. The report called the case an “attempted murder...
...will “Twilight” fans truly appreciate the satire? Thejal Srikumar ’13, whose favorite “Twilight” character is Alice Cullen, thinks “Nightlight” will be a hit. She says, although “some people might take [“Nightlight”] too seriously...the actual story itself isn’t supposed to be real in any way shape or form.” We’ll see in two weeks whether diehard fans agree...
...dealt with in the 1984 law because the industry was then in its infancy? A 2008 analysis by former Clinton Administration official Robert Shapiro, who has consulted for both biologics companies and their would-be generic competitors, suggested that generic versions of the top 12 categories of biologics whose patents have expired or will expire soon could save Americans up to $108 billion in the first 10 years and as much as $378 billion over two decades. "It's the low-hanging fruit," says Mark Merritt, head of the Pharmaceutical Care Management Association, the trade organization for prescription-drug-benefit...
...Eshoo's successful amendment to the Energy and Commerce Committee bill would extend that to 12 years of exclusivity, as would legislation passed a few weeks earlier by the Senate Health, Education, Labor and Pensions (HELP) Committee. Then-chairman Ted Kennedy, whose state of Massachusetts is home to many biotech firms, had long supported a 12-year exclusivity period. The industry showed its gratitude last year when Amgen, one of the biggest biotech firms, donated $5 million - twice the size of the next largest donation - to a nonprofit educational institute being built in Kennedy's honor. (Watch TIME's video...
...Similarly, on Oct. 19, PhRMA put out a statement calling for a "fair period of data protection" of 12 years at a "bare minimum." To defend its position, the group cited Duke University economist Henry Grabowski, whose work it has funded, and two patient groups. One, called RetireSafe, receives regular infusions of "general operating support" from Pfizer and operates out of a small Washington law-firm office. It has been blitzing Capitol Hill with letters arguing that guaranteeing biologics makers fewer than 12 years of exclusivity in the use of their data could cost lives. The other group, the Alliance...